The duration of Plasmodium falciparum infections

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Ashley, Elizabeth A ^a,b   White, Nicholas J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Asymptomatic; Longevity; Plasmodium falciparum; Sub microscopic; Transfusion malaria

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; DISEASE DURATION; GAMETOCYTE; HUMAN; LIMIT OF DETECTION; MALARIA FALCIPARUM; MICROSCOPY; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; REVIEW; ASYMPTOMATIC DISEASE; PATHOLOGY; TIME;

ASYMPTOMATIC DISEASES; HUMANS; MALARIA, FALCIPARUM; TIME FACTORS;

EID: 84924286675     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-500     Document Type: Review

References (70)

1. Collins WE, Jeffery GM: Plasmodium malariae: parasite and disease. Clin Microbiol Rev 2007, 20:579-592.
2. Brouwer EE, van Hellemond JJ, van Genderen PJ, Slot E, van Lieshout L, Visser LG, Wismans PJ: A case report of transfusion-transmitted Plasmodium malariae from an asymptomatic non-immune traveller. Malar J 2013, 12:439.
3. Jeffery GM, Eyles DE: The duration in the human host of infections with a Panama strain of Plasmodium falciparum. Am J Trop Med Hyg 1954, 3:219-224.
4. Eyles DE, Young MD: The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host. J Natl Malar Soc 1951, 10:327-336.
5. Covell G: Relationship between malarial parasitaemia and symptoms of the disease: a review of the literature. Bull World Health Organ 1960, 22:605-619.
6. Ciuca M, Lupasco G, Ballif-Negulici E, Constantinesco P, Cristesco A, Sandesco I: Experimental research on the infectivity for A. atroparvus of P. vivax or P. falciparum asymptomatic parasitaemias in relation to acquired immunity in countries where malaria is endemic. Geneva: World Health Organization; 1963. WHO-Mal-378.pdf.
7. Bruce-Chwatt LJ: Malaria research and eradication in the USSR. A review of Soviet achievements in the field of malariology. Bull World Health Organ 1959, 21:737-772.
8. Verdrager J: Observations on the longevity of Plasmodium falciparum: with special reference to findings in Mauritius. Bull World Health Organ 1964, 31:747-751.
9. Earle WC: The Course of Naturally Acquired Malaria. Geneva: World Health Organization; 1962. WHO-Mal-333.pdf.
10. Sama W, Killeen G, Smith T: Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am J Trop Med Hyg 2004, 70:625-634.
11. Hamad AA, El Hassan IM, El Khalifa AA, Ahmed GI, Abdelrahim SA, Theander TG, Arnot DE: Chronic Plasmodium falciparum infections in an area of low intensity malaria transmission in the Sudan. Parasitology 2000, 120:447-456.
12. al-Yaman F, Genton B, Reeder JC, Anders RF, Smith T, Alpers MP: Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. Trans R Soc Trop Med Hyg 1997, 91:602-605.
13. Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, Walliker D, Day KP: Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 2000, 121:257-272.
14. Bousema T, Drakeley C: Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 2011, 24:377-410.
15. Bidegain F, Berry A, Alvarez M, Verhille O, Huguet F, Brousset P, Pris J, Marchou B, Magnaval JF: Acute Plasmodium falciparum malaria following splenectomy for suspected lymphoma in 2 patients. Clin Infect Dis 2005, 40:e97-100.
16. Howden BP, Vaddadi G, Manitta J, Grayson ML: Chronic falciparum malaria causing massive splenomegaly 9 years after leaving an endemic area. Med J Aust 2005, 182:3.
17. Woolsey G: Transfusion for pernicious anemia: Two cases. Ann Surg 1911, 53:3.
18. Fairley NH: Sidelights on malaria in man obtained by subinoculation experiments. Trans R Soc Trop Med Hyg 1947, 40:621-676.
19. Bruce-Chwatt LJ: Transfusion malaria. Bull World Health Organ 1974, 50:337-346.
20. Website of the International Haemovigilance network. [http://www.ihn-org.com/]
21. Black RH: Investigation of blood donors in accidental transfusion malaria-Plasmodium vivax, falciparum and malariae infections. Med J Aust 1960, 2:446-449.
22. Chojnacki RE, Brazinsky JH, Barrett O Jr: Transfusion-introduced falciparum malaria. N Engl J Med 1968, 279:984-985.
23. Fisher GU, Schultz MG: Unusual host-parasite relationship in blood-donors responsible for transfusion-induced falciparum malaria. Lancet 1969, 2:716-718.
24. Brooks MH, Barry KG: Fatal transfusion malaria. Blood 1969, 34:806-810.
25. Dike A, Draper CC: A case of transfusion malaria due to Plasmodium falciparum with antibody studies of the donors. Trans R Soc Trop Med Hyg 1970, 64(1):1. PubMed PMID: 4909856.
26. Seligman SJ, Choa MS: Transfusion-induced falciparum malaria. JAMA 1971, 217:479.
27. Duizabo P, Romano P, Usdin JP, Barbizet J: [Transfusion induced malaria with serious mental disturbance. Report of a case](in French). Concours Med 1974, 96:3.
28. Besson P, Robert JF, Reviron J, Richard-Lenoble D, Gentilini M: A propos de deux observations de paludisme transfusionnel. Essai de prevention associant un test d'immunofluorescence indirecte aux criteres de selection clinique. Revue Francaise de Transfusion et Immuno-hematologie 1976, XIX:4.
29. Saleun JP, Baret M, Dauriac J: Resultats d'une enquire sur le paludisme post-transfusionnel en France entre 1960 et 1974. Revue Francaise de Transfusion et Immuno-hematologie 1976, XIX:11.
30. Duperval R, Longpre B, Madarnas P: Unexplained falciparum malaria in a patient with chronic lymphocytic leukemia. Can Med Assoc J 1979, 121:1585-1588.
31. Babinet J, Gay F, Bustos D, Dubarry M, Jaulmes D, Nguyen L, Gentilini M: Transmission of Plasmodium falciparum by heart transplant. BMJ 1991, 303:1515-1516.
32. Yarrish RL, Janas JS, Nosanchuk JS, Steigbigel RT, Nusbacher J: Transfusion malaria: treatment with exchange transfusion after delayed diagnosis. Arch Intern Med 1982, 142:187-188.
33. Stickland JF, Roberts AN, Williams V: Transfusion-induced malaria in Victoria. Med J Aust 1992, 157:499-500.
34. Slinger R, Giulivi A, Bodie-Collins M, Hindieh F, John RS, Sher G, Goldman M, Ricketts M, Kain KC: Transfusion-transmitted malaria in Canada. Can Med Assoc J 2001, 164:377-379.
35. Frey-Wettstein A, Maier M, Markwalder K, Münch U: A case of transfusion transmitted malaria in Switzerland. Swiss Med Wkly 2001, 131:320.
36. Eliades MJ, Shah S, Nguyen-Dinh P, Newman RD, Barber AM, Nguyen-Dinh P, Roberts JM, Mali S, Parise ME, Barber AM, Steketee R: Malaria surveillance-United States, 2003. MMWR Surveill Summ 2005, 54:25-40.
37. Bruneel F, Thellier M, Eloy O, Mazier D, Boulard G, Danis M, Bedos JP: Transfusion-transmitted malaria. Intensive Care Med 2004, 30:1851-1852.
38. Kitchen AD, Barbara JA, Hewitt PE: Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang 2005, 89:77-80.
39. Centers for Disease C, Prevention: Travel-associated Dengue surveillance-United States, 2006-2008. MMWR Morb Mortal Wkly Rep 2010, 59:715-719.
40. Mali S, Tan KR, Arguin PM: Division of Parasitic Diseases, Malaria CfGH, Centers for Disease Control and Prevention: Malaria surveillance-United States, 2009. MMWR Surveill Summ 2011, 60:1-15.
41. Mali S, Kachur SP, Arguin PM: Division of Parasitic Diseases, Malaria CfGH, Centers for Disease Control and Prevention: Malaria surveillance-United States, 2010. MMWR Surveill Summ 2012, 61:1-17.
42. Lefavour GS, Pierce JC, Frame JD: Renal transplant-associated malaria. JAMA 1980, 244:1820-1821.
43. Nagley L: Probable relapse of malignant tertian malaria after thirteen years. Lancet 1945, 2:773.
44. Walters J: Quiescent malarial parasites. BMJ 1960, i:1206-1207.
45. Russell PF, West LS, Manwell RD, Macdonald G: Practical Malariology. 2nd edition. London: Oxford University Press; 1963.
46. Revel MP, Datry A, Saint Raimond A, Lenoir G, Danis M, Gentilini M: Plasmodium falciparum malaria after three years in a non-endemic area. Trans R Soc Trop Med Hyg 1988, 82:832.
47. Kyrönseppä H, Tiula E, Repo H, Lähdevirta J: Diagnosis of falciparum malaria delayed by long incubation period and misleading presenting symptoms: life-saving role of manual leucocyte differential count. Scand J Infect Dis 1989, 21:117-118.
48. Krajden SP, Panisko DM, Tobe B, Yang J, Keystone JS: Prolonged infection with Plasmodium falciparum in a semi-immune patient. Trans R Soc Trop Med Hyg 1991, 85:731-732.
49. Shah S, Filler S, Causer LM, Rowe AK, Bloland PB, Barber AM, Roberts JM, Desai MR, Parise ME, Steketee RW: Malaria surveillance-United States, 2002. MMWR Surveill Summ 2004, 53:21-34.
50. Giobbia M, Tonon E, Zanatta A, Cesaris L, Vaglia A, Bisoffi Z: Late recrudescence of Plasmodium falciparum malaria in a pregnant woman: a case report. Int J Infect Dis 2005, 9:234-235.
51. Lesko CR, Arguin PM, Newman RD: Congenital malaria in the United States: a review of cases from 1966 to 2005. Arch Pediatr Adolesc Med 2007, 161:1062-1067.
52. Greenwood T, Vikerfors T, Sjoberg M, Skeppner G, Farnert A: Febrile Plasmodium falciparum malaria 4 years after exposure in a man with sickle cell disease. Clin Infect Dis 2008, 47:e39-41.
53. D'Ortenzio E, Godineau N, Fontanet A, Houze S, Bouchaud O, Matheron S, Le Bras J: Prolonged Plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis 2008, 14:324-326.
54. Theunissen C, Janssens P, Demulder A, Nouboussie D, Van-Esbroeck M, Van-Gompel A, Van-Denende J: Falciparum malaria in patient 9 years after leaving malaria-endemic area. Emerg Infect Dis 2009, 15:115-116.
55. Foca E, Zulli R, Buelli F, De Vecchi M, Regazzoli A, Castelli F: P. falciparum malaria recrudescence in a cancer patient. Infez Med 2009, 17:33-34.
56. Szmitko PE, Kohn ML, Simor AE: Plasmodium falciparum malaria occurring 8 years after leaving an endemic area. Diagn Microbiol Infect Dis 2009, 63:105-107.
57. Cullen KA, Arguin PM: Division of Parasitic Diseases, Malaria CfGH Centers for Disease Control and Prevention: Malaria surveillance-United States, 2011. MMWR Surveill Summ 2013, 62:1-17.
58. Monge-Maillo BN, Norman F, Pérez-Molina JA, Dìaz-Menéndez M, Rubio JM, López-Vélez R: Plasmodium falciparum in asymptomatic immigrants from sub-Saharan Africa, Spain. Emerg Infect Dis 2012, 18:356-357.
59. Berrevoets MA, Sprong T, Meis JF, Dofferhoff AS: Plasmodium falciparum malaria recrudescence occurring 2.5 years after leaving an endemic country. Neth J Med 2013, 71:426-428.
60. Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, Nosten F, Snounou G, White NJ: High throughput ultra-sensitive molecular techniques to quantify low density malaria parasitaemias. J Clin Microbiol 2014, 52:3303-3309.
61. Satoguina J, Walther B, Drakeley C, Nwakanma D, Oriero EC, Correa S, Corran P, Conway DJ, Walther M: Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia and Guinea Bissau. Malar J 2009, 8:274.
62. Hsiang MS, Hwang J, Kunene S, Drakeley C, Kandula D, Novotny J, Parizo J, Jensen T, Tong M, Kemere J, Dlamini S, Moonen B, Angov E, Dutta S, Ockenhouse C, Dorsey G, Greenhouse B: Surveillance for malaria elimination in Swaziland: a national cross-sectional study using pooled PCR and serology. PLoS One 2012, 7:e29550.
63. Moncunill G, Mayor A, Bardaji A, Puyol L, Nhabomba A, Barrios D, Aguilar R, Pinazo MJ, Almirall M, Soler C, Dlamini S, Moonen B, Angov E, Dutta S, Ockenhouse C, Dorsey G, Greenhouse B: Cytokine profiling in immigrants with clinical malaria after extended periods of interrupted exposure to Plasmodium falciparum. PLoS One 2013, 8:e73360.
64. Nguyen ML, Goff T, Gibble J, Steele WR, Leiby DA: Analyzing actual risk in malaria-deferred donors through selective serologic testing. Transfusion 2013, 53:1736-1743.
65. Barry AE, Leliwa-Sytek A, Tavul L, Imrie H, Migot-Nabias F, Brown SM, McVean GA, Day KP: Population genomics of the immune evasion (var) genes of Plasmodium falciparum. PLoS Pathog 2007, 3:e34.
66. WHO: World Malaria Report 2013. Geneva: World Health Organization; 2013.
67. World Health Organisation: 10 facts on blood transfusion. http://www.who.int/features/factfiles/blood-transfusion/en/
68. Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland Ø, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S: The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010, 98:468-478.
69. Vamvakas EC, Blajchman MA: Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007, 21:327-348.
70. Marangi M, Di Tullio R, Mens PF, Martinelli D, Fazio V, Angarano G, Schallig HD, Giangaspero A, Scotto G: Prevalence of Plasmodium spp. in malaria asymptomatic African migrants assessed by nucleic acid sequence based amplification. Malar J 2009, 8:12.